Who we are
SLC6A1 Europe – Research & Support Alliance (SERSA) is a collaborative network uniting national patient organisations, families, clinicians, researchers and partners across Europe.
We work at the intersection of science and community.
For families, we provide trusted information, peer support and access to a strong European network.
For clinicians and researchers, we foster collaboration, facilitate meaningful patient engagement and help advance translational research.
For industry partners, we offer a unified European patient voice that supports responsible and efficient therapeutic development.
What does SERSA stand for?
The name SERSA reflects the core elements of our identity:
SLC6A1
The rare neurodevelopmental disorder at the heart of our work.
Europe
Connecting families, clinicians, researchers and patient organisations across Europe.
Research
Advancing scientific discovery, clinical trials, and therapeutic development.
Support
Empowering families with trusted information, connection and guidance.
Alliance
Bringing together national organisations into one coordinated European voice.
As an alliance rather than a single national organisation, SERSA strengthens collaboration across borders, reduces fragmentation, and accelerates progress in research, clinical care, and therapeutic development.
By working together, we achieve far more than any organisation could alone.
Our Commitment
We connect families, researchers, clinicians and partners across Europe to advance SLC6A1 research and therapeutic development.
We are SERSA
We work to accelerate the development of
targeted treatments for SLC6A1.